• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫烯酰基 ACP 还原酶的动力学及其对药物发现的影响。

Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery.

机构信息

Department of Pharmacology, University of California San Diego, La Jolla, California 92093, USA.

出版信息

Protein Sci. 2012 Nov;21(11):1734-45. doi: 10.1002/pro.2155. Epub 2012 Oct 9.

DOI:10.1002/pro.2155
PMID:22969045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3527710/
Abstract

Enoyl-acyl carrier protein reductase (ENR) is a crucial enzyme in the type II fatty acid synthesis pathway of many pathogens such as Plasmodium falciparum, the etiological agent of the most severe form of malaria. Because of its essential function of fatty acid double bond reduction and the absence of a human homologue, PfENR is an interesting drug target. Although extensive knowledge of the protein structure has been gathered over the last decade, comparatively little remains known about the dynamics of this crucial enzyme. Here, we perform extensive molecular dynamics simulations of tetrameric PfENR in different states of cofactor and ligand binding, and with a variety of different ligands bound. A pocket-volume analysis is also performed, and virtual screening is used to identify potential druggable hotspots. The implications of the results for future drug-discovery projects are discussed.

摘要

烯酰基辅酶 A 还原酶(ENR)是许多病原体(如疟原虫,即最严重疟疾形式的病原体)中 II 型脂肪酸合成途径的关键酶。由于其脂肪酸双键还原的重要功能以及缺乏人类同源物,PfENR 是一个有趣的药物靶点。尽管在过去十年中已经收集了大量关于该蛋白质结构的知识,但关于这种关键酶的动力学却知之甚少。在这里,我们对不同辅助因子和配体结合状态以及结合了各种不同配体的四聚体 PfENR 进行了广泛的分子动力学模拟。还进行了口袋体积分析,并进行了虚拟筛选以识别潜在的可成药热点。讨论了这些结果对未来药物发现项目的意义。

相似文献

1
Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery.恶性疟原虫烯酰基 ACP 还原酶的动力学及其对药物发现的影响。
Protein Sci. 2012 Nov;21(11):1734-45. doi: 10.1002/pro.2155. Epub 2012 Oct 9.
2
High-resolution structures of Thermus thermophilus enoyl-acyl carrier protein reductase in the apo form, in complex with NAD+ and in complex with NAD+ and triclosan.嗜热栖热菌烯酰-酰基载体蛋白还原酶的高分辨率结构,分别为无配体形式、与NAD⁺结合的复合物形式以及与NAD⁺和三氯生结合的复合物形式。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Oct 1;68(Pt 10):1139-48. doi: 10.1107/S1744309112033982. Epub 2012 Sep 22.
3
Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum.恶性疟原虫烯脂酰-ACP(酰基载体蛋白)还原酶三氯生结合区域的突变分析。
Biochem J. 2004 Aug 1;381(Pt 3):735-41. doi: 10.1042/BJ20040302.
4
Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of with Favourable ADME Profiles.基于结构的设计和基于药效团的虚拟筛选三氯生类似物组合文库对酰基辅酶 A 还原酶的活性与有利的 ADME 概况。
Int J Mol Sci. 2023 Apr 7;24(8):6916. doi: 10.3390/ijms24086916.
5
Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum.三氯生和烟酰胺腺嘌呤二核苷酸与恶性疟原虫烯酰-ACP还原酶结合的结构基础。
Biochem Biophys Res Commun. 2001 Apr 27;283(1):224-8. doi: 10.1006/bbrc.2001.4747.
6
Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening.通过基于结构的虚拟筛选发现靶向恶性疟原虫烯酰-酰基载体蛋白还原酶的新型抑制剂。
Biochem Biophys Res Commun. 2007 Jul 6;358(3):686-91. doi: 10.1016/j.bbrc.2007.04.113. Epub 2007 Apr 26.
7
Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.雷公藤红素抑制恶性疟原虫烯脂酰-酰基载体蛋白还原酶。
Bioorg Med Chem. 2014 Nov 1;22(21):6053-6061. doi: 10.1016/j.bmc.2014.09.002. Epub 2014 Sep 15.
8
Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase.抗菌剂三氯生对疟疾烯酰酰基载体蛋白还原酶特异性的结构解析。
J Biol Chem. 2002 Apr 12;277(15):13106-14. doi: 10.1074/jbc.M112000200. Epub 2002 Jan 15.
9
Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches.通过配体和基于结构的药物设计方法发现疟原虫烯酰基辅酶 A 还原酶的新潜在药物。
Bioorg Med Chem Lett. 2013 Apr 15;23(8):2436-41. doi: 10.1016/j.bmcl.2013.02.006. Epub 2013 Feb 13.
10
Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents.弓形虫和恶性疟原虫烯酰酰基载体蛋白还原酶的研究及其对抗寄生虫药物开发的意义。
Acta Crystallogr D Biol Crystallogr. 2007 Mar;63(Pt 3):328-38. doi: 10.1107/S0907444906053625. Epub 2007 Feb 21.

引用本文的文献

1
Exploring Novel Antimalarial Compounds Targeting Enoyl-ACP Reductase: Computational and Experimental Insights.探索靶向烯酰-ACP还原酶的新型抗疟化合物:计算与实验见解
ACS Omega. 2024 May 13;9(21):22777-22793. doi: 10.1021/acsomega.3c09893. eCollection 2024 May 28.
2
Antimalarial Properties of Isoquinoline Derivative from subsp. Hygroscopicus: An In Silico Approach.从 Hygroscopicus 的亚种中提取的异喹啉衍生物的抗疟特性:一种计算机模拟方法。
Biomed Res Int. 2020 Jan 9;2020:6135696. doi: 10.1155/2020/6135696. eCollection 2020.
3
Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations.结核分枝杆菌InhA的慢发性抑制:通过分子动力学模拟揭示停留时间的分子决定因素
PLoS One. 2015 May 21;10(5):e0127009. doi: 10.1371/journal.pone.0127009. eCollection 2015.
4
POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics.POVME 2.0:一种用于确定袋状形状和容积特征的增强工具。
J Chem Theory Comput. 2014 Nov 11;10(11):5047-5056. doi: 10.1021/ct500381c. Epub 2014 Sep 29.
5
In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.恶性疟原虫烯脂酰-ACP还原酶抑制剂的计算机筛选
J Comput Aided Mol Des. 2015 Jan;29(1):79-87. doi: 10.1007/s10822-014-9806-3. Epub 2014 Oct 25.
6
Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.雷公藤红素抑制恶性疟原虫烯脂酰-酰基载体蛋白还原酶。
Bioorg Med Chem. 2014 Nov 1;22(21):6053-6061. doi: 10.1016/j.bmc.2014.09.002. Epub 2014 Sep 15.

本文引用的文献

1
Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 - 2010).烯酰基辅酶 A 还原酶抑制剂:专利分析(2006-2010)
Expert Opin Ther Pat. 2011 Jul;21(7):1007-22. doi: 10.1517/13543776.2011.581227. Epub 2011 Jun 9.
2
Molecular dynamics simulations of protein targets identified in Mycobacterium tuberculosis.结核分枝杆菌中鉴定的蛋白质靶标的分子动力学模拟。
Curr Med Chem. 2011;18(9):1353-66. doi: 10.2174/092986711795029519.
3
Applying molecular dynamics simulations to identify rarely sampled ligand-bound conformational states of undecaprenyl pyrophosphate synthase, an antibacterial target.运用分子动力学模拟技术,鉴定十一烯基焦磷酸合酶(一种抗菌靶标)结合配体的罕见构象状态。
Chem Biol Drug Des. 2011 Jun;77(6):412-20. doi: 10.1111/j.1747-0285.2011.01101.x. Epub 2011 Mar 29.
4
Effect of substrate binding loop mutations on the structure, kinetics, and inhibition of enoyl acyl carrier protein reductase from Plasmodium falciparum.底物结合环突变对恶性疟原虫烯酰基辅酶 A 还原酶的结构、动力学和抑制作用的影响。
IUBMB Life. 2011 Jan;63(1):30-41. doi: 10.1002/iub.412. Epub 2011 Jan 13.
5
POVME: an algorithm for measuring binding-pocket volumes.POVME:一种用于测量结合口袋体积的算法。
J Mol Graph Model. 2011 Feb;29(5):773-6. doi: 10.1016/j.jmgm.2010.10.007. Epub 2010 Nov 3.
6
Structural basis of triclosan resistance.三氯生耐药性的结构基础。
J Struct Biol. 2011 Apr;174(1):173-9. doi: 10.1016/j.jsb.2010.11.008. Epub 2010 Nov 19.
7
X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition.X 射线晶体学分析恶性疟原虫烯酰基辅酶 A 还原酶与三氯生变体的复合物,以阐明不同功能基团在酶抑制中的重要性。
IUBMB Life. 2010 Jun;62(6):467-76. doi: 10.1002/iub.327.
8
Evaluation of enoyl-acyl carrier protein reductase inhibitors as Pseudomonas aeruginosa quorum-quenching reagents.评价酰基辅酶 A 还原酶抑制剂作为铜绿假单胞菌群体感应淬灭试剂。
Molecules. 2010 Feb 3;15(2):780-92. doi: 10.3390/molecules15020780.
9
The origin of malignant malaria.恶性疟疾的起源。
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14902-7. doi: 10.1073/pnas.0907740106. Epub 2009 Aug 3.
10
Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques.使用傅里叶域相关技术基于片段鉴定蛋白质的可成药“热点”
Bioinformatics. 2009 Mar 1;25(5):621-7. doi: 10.1093/bioinformatics/btp036. Epub 2009 Jan 28.